-
Diagnostics World News | In the opening plenary panel for the Molecular and Precision Med Tri-Con this week, Robert Green, Brigham and Women’s Hospital, led a group in exploring how genomics, digital health, and more will converge to deliver precision health. He was joined by Megan Mahoney, Stanford University; Jessica Mega, Verily Life Sciences; Sir Mark Caulfield, Barts Life Sciences & Queen Mary University of London; and Lara Jehi, Cleveland Clinic.
Feb 24, 2022
-
Diagnostics World | On the first morning of the Molecular & Precision Med Tri-Con event, Viktor Adalsteinsson, associate director of the Gerstner Center for Cancer Diagnostics at the Broad Institute, explored new tools and techniques for detecting minimal residual disease.
Feb 22, 2022
-
Diagnostics World News | Schools, airports, and other venues where large numbers of people congregate could start using a new smartphone-based diagnostic platform that rapidly and inexpensively tests for both COVID-19 and the flu from a small volume of saliva.
Feb 17, 2022
-
Diagnostics World News | Researchers in Norway have used cytokine profiling to create a baseline for what the immune system looks like in normal pregnancies as a starting point for discerning when something is going wrong—preeclampsia, for example. As it turns out, immune activity predictably modulates throughout uneventful pregnancies.
Feb 15, 2022
-
Diagnostics World News | Immunotherapies vary widely in their ability to effectively treat patients with cancer, and the reason is the differing immune states of their tumor. Only a finite number of “immune archetypes” exist across all cancers—and these distinct environments are inhabited by more than the T cells targeted by currently marketed immunotherapy drugs.
Feb 10, 2022
-
Diagnostics World | New developments in the realm of breast cancer detection continue to emerge, from recent research and partnerships newly forged to the launch of new tools and technologies.
Feb 9, 2022
-
Diagnostics World | AI-driven diagnostics for gastroenterology, live-cell super-resolution microscopy, AI-based risk stratification for breast and prostate cancer, and more.
Feb 8, 2022
-
Diagnostics World | The healthcare industry not only appears ready for AI, some of its most digitally progressive players are already actively embracing it. These early use cases have begun to hint at AI’s potential value to healthcare providers, for its ability to provide an elevated level of data intelligence that could significantly improve patient outcomes and the overall patient experience, and on the business side, for its ability to improve efficiency and innovation.
Feb 3, 2022
-
Diagnostics World News | Skin health, single-cell spatial genomics, diabetic kidney disease, MS biomarkers, lung and colorectal cancer screening. Plus: home testing of peripheral neuropathies, new COVID tests, and more.
Feb 2, 2022
-
Diagnostics World News | Elaine Gee is Principal Data Scientist at Mirvie, a company dedicated to using technology to improve maternal health and identify pregnancy complications early using blood-based RNA profiling.
Jan 28, 2022
-
Diagnostics World News | Researchers at Mount Sinai and the University of Colorado are pursuing the possibilities that stem from predicting which COVID-19 patients are most likely to deteriorate over time. The hope is that this ability could help health care professionals more effectively triage patients and pair them with appropriate treatments to improve outcomes.
Jan 27, 2022
-
Diagnostics World News | It has proven exceedingly difficult to identify reliable and reproducible genetic markers for depression, but it now appears possible to efficiently leverage a biochemical hallmark to create a blood test. The basis of the test is the four-decade-old discovery that depression is tied to low levels of the intracellular molecule adenylyl cyclase, made in response to neurotransmitters such as serotonin and epinephrine.
Jan 25, 2022
-
Diagnostics World | Researchers at the University of Michigan (U-M) have made the connection between cellular motility—with a known connection to tumor metastasis—and the shape-shifting behavior of cancer cells to become more “missile-like” and thus better able to make the voyage from one site in the body to another. The newly acquired characteristic arises when epithelial cells morph into mesenchymal cells, but the transition can’t be seen if the cells are all held hostage on a glass microscope slide.
Jan 19, 2022
-
Diagnostics World News | At the JP Morgan Healthcare Conference—being held virtually again this year—diagnostics companies gave overviews of their 2021 business and their views of the future. Here are the highlights we noted from presentations from Thermo Fisher Scientific, Abbott, and Natera.
Jan 17, 2022
-
Diagnostics World News | Mammography has a lot of well-recognized shortcomings among women with dense breasts as well as those diagnosed with breast cancer who need their response to therapy closely monitored. A cheaper, noninvasive, and easy-to-perform test is now under development that could solve for its clinical limitations and is on track to hit the market as early as 2023.
Jan 13, 2022
-
Diagnostics World | Speaking at the 2022 JP Morgan Healthcare Conference—being held virtually again this year—deSouza, the CEO of Illumina, outlined the sequencing giant’s plans for expanding their diagnostic capabilities and business.
Jan 11, 2022
-
Diagnostics World News | We spoke with the vendor community of Diagnostics World to gather predictions for the coming year. They gave us additional forecasts for imaging data infrastructures, staffing shortage remedies, SaaS medical devices, avoiding bias in AI algorithms, and more.
Jan 10, 2022
-
Diagnostics World News | Researchers in Australia have succeeded in building a chemically induced dimerization (CID) system that can detect the concentration of the antimetabolite drug methotrexate in serum. Coupled with a functionally related biosensor of rapamycin, commonly used to prevent organ transplant rejection, they also looked at lab prototypes of a multiplexed bioelectronic system for repeated measurements of multiple analytes.
Jan 6, 2022
-
Diagnostics World | A global collaborative of researchers has used a novel platform based on cell-free RNA (cfRNA) to monitor patterns of gene expression as pregnancy progresses—including, surprisingly, genes that appear to originate with the developing fetus. They recently demonstrated the platform’s potential as a pregnancy screening tool, using preeclampsia as a test case, but it might logically also be brought to bear in the future treatment and prevention of any number of pregnancy-related complications.
Jan 5, 2022
-
Diagnostics World | Researchers in China have developed a noninvasive skin cholesterol detection system that could be useful in the long-term lipid management of cardiovascular diseases, meeting a critical unmet need.
Jan 4, 2022